1. Home
  2. SNPS vs MCK Comparison

SNPS vs MCK Comparison

Compare SNPS & MCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNPS
  • MCK
  • Stock Information
  • Founded
  • SNPS 1986
  • MCK 1833
  • Country
  • SNPS United States
  • MCK United States
  • Employees
  • SNPS N/A
  • MCK N/A
  • Industry
  • SNPS EDP Services
  • MCK Other Pharmaceuticals
  • Sector
  • SNPS Technology
  • MCK Health Care
  • Exchange
  • SNPS Nasdaq
  • MCK Nasdaq
  • Market Cap
  • SNPS 86.8B
  • MCK 73.6B
  • IPO Year
  • SNPS 1992
  • MCK N/A
  • Fundamental
  • Price
  • SNPS $492.18
  • MCK $579.43
  • Analyst Decision
  • SNPS Strong Buy
  • MCK Strong Buy
  • Analyst Count
  • SNPS 11
  • MCK 13
  • Target Price
  • SNPS $646.36
  • MCK $639.00
  • AVG Volume (30 Days)
  • SNPS 1.4M
  • MCK 903.1K
  • Earning Date
  • SNPS 02-19-2025
  • MCK 02-05-2025
  • Dividend Yield
  • SNPS N/A
  • MCK 0.49%
  • EPS Growth
  • SNPS 83.13
  • MCK N/A
  • EPS
  • SNPS 14.52
  • MCK 19.33
  • Revenue
  • SNPS $6,127,436,000.00
  • MCK $330,187,000,000.00
  • Revenue This Year
  • SNPS $13.16
  • MCK $17.68
  • Revenue Next Year
  • SNPS $12.97
  • MCK $9.52
  • P/E Ratio
  • SNPS $53.21
  • MCK $30.00
  • Revenue Growth
  • SNPS 15.22
  • MCK 13.43
  • 52 Week Low
  • SNPS $457.52
  • MCK $450.33
  • 52 Week High
  • SNPS $629.38
  • MCK $637.51
  • Technical
  • Relative Strength Index (RSI)
  • SNPS 37.92
  • MCK 46.38
  • Support Level
  • SNPS $492.25
  • MCK $558.13
  • Resistance Level
  • SNPS $525.33
  • MCK $585.50
  • Average True Range (ATR)
  • SNPS 16.99
  • MCK 11.97
  • MACD
  • SNPS -4.97
  • MCK -5.31
  • Stochastic Oscillator
  • SNPS 7.93
  • MCK 30.56

About SNPS Synopsys Inc.

Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.

About MCK McKesson Corporation

McKesson Corp is one of three leading pharmaceutical wholesalers in the us engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the us pharmaceutical wholesale industry. Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Share on Social Networks: